Immune Pharma (IMNP) Announces Corporate Restructuring, CEO to Resign – StreetInsider.com
Get access to the best calls on Wall Street with StreetInsider.com’s Ratings Insider Elite. Get your Free Trial here. Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced a major corporate restructuring with the objective of prioritizing and segregating its research and development efforts on a focused set of products in inflammatory disease and dermatology and strengthening its…